TP53 and ovarian carcinoma: To confirm the anti-tumorigenic effects of plakoglobin on exogenously expressed p53 mutants, p53-175 and -273 mutants were transiently expressed in SKOV-3 ovarian carcinoma cells–which constitute a different cellular background to H1299 cells, and invasion assays were performed on the transfectants.